Directors’ Dealings | 8 May 2014 09:42

DGAP-DD: Biotest AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a company of EQS Group AG. The person with duty of notification is solely responsible for the content of this announcement. ————————————————————————— Details of the person subject to the disclosure requirement Last name: Prof. Dr. Rothenburger First name: Markus Company: Biotest AG Position: Division Head of Medical/Regulatory Affairs Information about the transaction with duty of notification Description of the financial instrument: Preference Shares ISIN/WKN of the financial instrument: DE0005227235 Type of transaction: Purchase Date: 08.05.2014 Price: 85.79 Currency: EUR No. of items: 250 Total amount traded: 21447.50 Place: Stuttgart Information about the company with duty of publication Issuer: Biotest AG Landsteinerstraße 5 63303 Dreieich Deutschland ISIN: DE0005227235 WKN: 522723 End of Directors’ Dealings Notification (c) DGAP 08.05.2014 DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de ID 18719